News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Julie Gralow: Trainee and Early Career Lounge for Panel Talks at ASCO25
Julie Gralow/citycancerchallenge.org
May 12, 2025, 10:44

Julie Gralow: Trainee and Early Career Lounge for Panel Talks at ASCO25

Julie Gralow, Chief Medical Officer (CMO) of the American Society of Clinical Oncology (ASCO), shared a post on X:

“If you’re a trainee or early career attending ASCO25, stop by the Trainee and Early Career Lounge for Panel Talks, Roundtable Sessions, and Networking Events (+ mentoring and refreshments!).”

More posts featuring Julie Gralow.

American Society of Clinical Oncology ASCO ASCO25 cancer fight against cancer Global fight against cancer Julie Gralow OncoDaily Oncology
Special Coverage
Blog
Jun 3, 2025, 10:56
Giannis Mountzios: ASCO25 is About Science, Research, Care but Also Your Second Family - Colleagues and Friends
Blog
Jun 3, 2025, 10:50
Paolo Tarantino: We need Biomarkers to Tailor Treatment with T-DXd
Opinion
Jun 3, 2025, 10:41
TRIgnite-1 study at ASCO 2025 showed High Response Rates and Favorable Safety Profile for the Treatment of Relapsed/Refractory Multiple Myeloma with First-in-Class BCMA × CD38 × CD3 Trispecific Antibody 
Blog
Jun 3, 2025, 10:35
Mario Balsa Shares ASCENT-04 Trial Results in First-Line mTNBC at ASCO25
Blog
Jun 3, 2025, 10:33
Vivek Subbiah: Waiting for ASCO 2025 Hematology Discussions with Naveen Pemmaraju
Blog
Jun 3, 2025, 10:27
Supriya Peshin Reflects on a Memorable Moment with Oncology Colleagues
Blog
Jun 3, 2025, 09:54
Robin Zon: ASCO 2025 President’s Address - “Driving Knowledge to Action: Building a Better Future”
Science
Jun 3, 2025, 09:52
Breaking research on GLP-1s and cancer from ASCO 2025
Blog
Jun 3, 2025, 09:48
Rami Manochakian: Results of ALNEO Phase 2 Trial at ASCO25
Blog
Jun 3, 2025, 09:33
Sagal Pannu: Tarlatamab and Emerging Bispecific T-cell Engagers Changing the Treatment Landscape of SCLC
Blog
Jun 3, 2025, 09:25
Nehemias Guevara-Rodriguez: Honored to Meet Saad Z. Usmani a Giant in Cancer Care
Blog
Jun 3, 2025, 09:15
Harold J. Burstein: First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer